{"id":"oral-sulfate-tablet-2-day","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal cramping"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Bloating"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sulfate salts are poorly absorbed in the gastrointestinal tract and create an osmotic gradient that increases intraluminal fluid volume, stimulating peristalsis and facilitating stool passage. The 2-day formulation likely refers to a dosing regimen or extended-release delivery designed to provide sustained laxative effect over a 48-hour period.","oneSentence":"Oral sulfate acts as an osmotic laxative that draws water into the intestinal lumen to promote bowel evacuation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:50:45.393Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Constipation"},{"name":"Bowel preparation"}]},"trialDetails":[{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":"HIV Infections","enrollment":631},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":"Creutzfeldt-Jakob Disease","enrollment":246},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT07476508","phase":"NA","title":"\"Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy\"","status":"COMPLETED","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2019-10-10","conditions":"Meniscus Lesion, Knee Injuries, Medial Meniscus Tear","enrollment":290},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT06286046","phase":"PHASE2","title":"A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2026-03","conditions":"Sickle Cell Disease, Nephropathy","enrollment":40},{"nctId":"NCT05144256","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-08","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":49},{"nctId":"NCT01931696","phase":"NA","title":"Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-08","conditions":"Asthma","enrollment":200},{"nctId":"NCT06408298","phase":"EARLY_PHASE1","title":"HCQ in Resectable Localized Prostate Cancer","status":"RECRUITING","sponsor":"Lionel.D.Lewis, MD","startDate":"2026-01-06","conditions":"Resectable Localized Prostate Cancer","enrollment":20},{"nctId":"NCT01391962","phase":"PHASE2","title":"Sunitinib or Cediranib for Alveolar Soft Part Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-07-18","conditions":"Sarcoma, Alveolar Soft Part","enrollment":34},{"nctId":"NCT07340450","phase":"NA","title":"Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-02-18","conditions":"Postpartum Anaemia","enrollment":122},{"nctId":"NCT02302547","phase":"PHASE3","title":"Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2014-12","conditions":"HIV","enrollment":224},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT03853798","phase":"PHASE3","title":"Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2019-03-21","conditions":"Pyruvate Kinase Deficiency","enrollment":90},{"nctId":"NCT04007562","phase":"","title":"Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-11-04","conditions":"LIPIN1 Deficiency","enrollment":""},{"nctId":"NCT06652113","phase":"NA","title":"Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-11-15","conditions":"Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies","enrollment":796},{"nctId":"NCT03377179","phase":"PHASE2","title":"A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2018-03-07","conditions":"Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Perihilar","enrollment":65},{"nctId":"NCT05099107","phase":"NA","title":"Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2021-10-25","conditions":"Congenital Myopathy, Neuromuscular Diseases, Musculoskeletal Diseases","enrollment":18},{"nctId":"NCT06032442","phase":"NA","title":"A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"NPO Petrovax","startDate":"2022-03-21","conditions":"Osteoarthritis, Osteo Arthritis Knee, Osteoarthritis, Knee","enrollment":70},{"nctId":"NCT06847139","phase":"NA","title":"Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis","status":"RECRUITING","sponsor":"Chittagong Medical College","startDate":"2024-07-01","conditions":"Chronic Kidney Disease Requiring Hemodialysis","enrollment":90},{"nctId":"NCT04785768","phase":"PHASE3","title":"IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration","status":"COMPLETED","sponsor":"Fujian Cancer Hospital","startDate":"2021-07-01","conditions":"Cancer Pain","enrollment":1372},{"nctId":"NCT06851130","phase":"NA","title":"Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women","status":"RECRUITING","sponsor":"Swiss Federal Institute of Technology","startDate":"2025-02-25","conditions":"Iron Deficiency Without Anemia","enrollment":120},{"nctId":"NCT05949008","phase":"PHASE4","title":"Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-11-22","conditions":"NIDDM, Obesity","enrollment":150},{"nctId":"NCT04011410","phase":"PHASE2","title":"Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer","status":"COMPLETED","sponsor":"Patrick Hensley","startDate":"2019-12-03","conditions":"Prostate Cancer Recurrent","enrollment":20},{"nctId":"NCT05813496","phase":"PHASE4","title":"Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt","status":"COMPLETED","sponsor":"Eva Pharma","startDate":"2022-10-26","conditions":"Polyneuropathy, Diabetic","enrollment":430},{"nctId":"NCT04841148","phase":"PHASE2","title":"Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer","status":"RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2021-06-01","conditions":"Breast Cancer","enrollment":96},{"nctId":"NCT06648824","phase":"PHASE1","title":"Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2024-10-17","conditions":"Healthy Participants","enrollment":20},{"nctId":"NCT06091735","phase":"NA","title":"Clinical Study of Bowel Preparation Before Colonoscopy","status":"COMPLETED","sponsor":"Jinling Hospital, China","startDate":"2023-08-01","conditions":"Bowel Preparation","enrollment":444},{"nctId":"NCT03030417","phase":"PHASE1","title":"Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-02-27","conditions":"Solid Tumors, Lymphoma","enrollment":36},{"nctId":"NCT02275780","phase":"PHASE3","title":"Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-12-01","conditions":"HIV-1","enrollment":769},{"nctId":"NCT04315948","phase":"PHASE3","title":"Trial of Treatments for COVID-19 in Hospitalized Adults","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-03-22","conditions":"Corona Virus Infection","enrollment":1552},{"nctId":"NCT05127486","phase":"PHASE4","title":"A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-12-06","conditions":"Migraine, Episodic Migraine","enrollment":580},{"nctId":"NCT02120352","phase":"PHASE2","title":"A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2014-04-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":309},{"nctId":"NCT03732638","phase":"PHASE2, PHASE3","title":"Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-11-14","conditions":"Migraine","enrollment":1590},{"nctId":"NCT06432101","phase":"NA","title":"Acupuncture Combined With Hydroxychloroquine","status":"COMPLETED","sponsor":"Senyue Zhang","startDate":"2023-01-01","conditions":"Primary Sjögren's Syndrome","enrollment":65},{"nctId":"NCT03430817","phase":"PHASE4","title":"Citicholine-Amantadine Trial in Traumatic Brain Injury","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-12-07","conditions":"Intensive Care Unit","enrollment":45},{"nctId":"NCT05358509","phase":"PHASE4","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-03-15","conditions":"Iron Deficiency Anemia, Infant, Low Birth Weight, Anemia of Pregnancy","enrollment":4368},{"nctId":"NCT01851369","phase":"PHASE1, PHASE2","title":"TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-07-12","conditions":"Lymphomas, Solid Tumors, NSCLC","enrollment":93},{"nctId":"NCT04017598","phase":"PHASE4","title":"Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2019-12-10","conditions":"Anemia, Iron Deficiency, Anemia, Intestinal Inflammation","enrollment":480},{"nctId":"NCT04341727","phase":"PHASE3","title":"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2020-04-04","conditions":"Coronavirus Infection","enrollment":30},{"nctId":"NCT06366698","phase":"PHASE3","title":"Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-11-21","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":900},{"nctId":"NCT03457701","phase":"PHASE2","title":"Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-07-30","conditions":"Anaemia","enrollment":15},{"nctId":"NCT06315387","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers","status":"UNKNOWN","sponsor":"Valenta Pharm JSC","startDate":"2023-12-04","conditions":"Cholecystitis","enrollment":42},{"nctId":"NCT01620944","phase":"PHASE3","title":"Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC","status":"TERMINATED","sponsor":"Bristol-Myers Squibb","startDate":"2012-07-31","conditions":"HIV","enrollment":3},{"nctId":"NCT01605084","phase":"PHASE3","title":"Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone","status":"WITHDRAWN","sponsor":"Bristol-Myers Squibb","startDate":"2012-06-30","conditions":"HIV","enrollment":""},{"nctId":"NCT04205266","phase":"PHASE4","title":"IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2020-02-14","conditions":"Anemia, Iron Deficiency, Heavy Menstrual Bleeding","enrollment":76},{"nctId":"NCT05923918","phase":"PHASE3","title":"A Study to Evaluate Safety and Efficacy of PBK_M2101","status":"UNKNOWN","sponsor":"Pharmbio Korea Co., Ltd.","startDate":"2023-06","conditions":"Intestinal Disease, Colonic Diseases, Gastrointestinal Disease","enrollment":246},{"nctId":"NCT04946461","phase":"","title":"The Day-time Response Variation of (Lis)Dexamphetamine","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2021-07-01","conditions":"Adhd","enrollment":16},{"nctId":"NCT03461757","phase":"PHASE3","title":"Trial in Adult Subjects With Acute Migraines","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-02-27","conditions":"Migraine, With or Without Aura","enrollment":1811},{"nctId":"NCT05647330","phase":"PHASE2","title":"Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2022-12-15","conditions":"Hydroxychloroquine, Gemcitabine, Lung Neoplasms","enrollment":55},{"nctId":"NCT05236738","phase":"PHASE1","title":"A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2022-05-13","conditions":"Healthy Participants","enrollment":42},{"nctId":"NCT03657433","phase":"PHASE3","title":"Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2018-12-17","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":124},{"nctId":"NCT03957057","phase":"PHASE3","title":"Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-10","conditions":"Postpartum Anemia Nos, Iron-deficiency","enrollment":300},{"nctId":"NCT03449459","phase":"EARLY_PHASE1","title":"Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-12-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":144},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":"Iron Deficiency Anemia","enrollment":79},{"nctId":"NCT05152641","phase":"PHASE2","title":"Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery","status":"WITHDRAWN","sponsor":"BioAge Labs, Inc.","startDate":"2022-04","conditions":"Acute Posthemorrhagic Anemia","enrollment":""},{"nctId":"NCT02163356","phase":"PHASE1","title":"Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma","status":"TERMINATED","sponsor":"South Plains Oncology Consortium","startDate":"2014-05","conditions":"Recurrent Neuroblastoma, Neuroblastoma","enrollment":4},{"nctId":"NCT05279586","phase":"EARLY_PHASE1","title":"Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients","status":"UNKNOWN","sponsor":"Madonna Magdy Fahmy","startDate":"2022-03","conditions":"Hepatic Encephalopathy","enrollment":316},{"nctId":"NCT04452565","phase":"PHASE2, PHASE3","title":"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection","status":"UNKNOWN","sponsor":"Biomed Industries, Inc.","startDate":"2022-06-15","conditions":"Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":525},{"nctId":"NCT05178953","phase":"EARLY_PHASE1","title":"The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia","status":"UNKNOWN","sponsor":"Arak University of Medical Sciences","startDate":"2021-08-01","conditions":"Men Infertility","enrollment":160},{"nctId":"NCT05156684","phase":"NA","title":"Effect of Pentoxifylline and Zinc Co-administration in Patients With Oligoasthenoteratozoospermia","status":"UNKNOWN","sponsor":"Arak University of Medical Sciences","startDate":"2022-01-01","conditions":"Idiopathic Infertility","enrollment":140},{"nctId":"NCT05140096","phase":"PHASE1","title":"A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult Participants","status":"COMPLETED","sponsor":"Acerta Pharma BV","startDate":"2020-01-03","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT00074581","phase":"PHASE3","title":"Preventing Sexual Transmission of HIV With Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-02","conditions":"HIV Infections","enrollment":3526},{"nctId":"NCT00270296","phase":"PHASE2","title":"Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-06","conditions":"HIV Infections","enrollment":730},{"nctId":"NCT02874287","phase":"PHASE4","title":"Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.","status":"COMPLETED","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2017-10-08","conditions":"Coronary Artery Disease","enrollment":35},{"nctId":"NCT01964378","phase":"PHASE3","title":"CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer","status":"TERMINATED","sponsor":"Tris Pharma, Inc.","startDate":"2013-10-29","conditions":"Pain, Neoplasms, Chronic Pain","enrollment":200},{"nctId":"NCT04234516","phase":"PHASE4","title":"Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder","status":"WITHDRAWN","sponsor":"New York State Psychiatric Institute","startDate":"2020-01-20","conditions":"Opioid-use Disorder, Suicidal Ideation","enrollment":""},{"nctId":"NCT03471988","phase":"PHASE3","title":"Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis","status":"COMPLETED","sponsor":"Asahi Kasei Pharma Corporation","startDate":"2018-04-16","conditions":"Deep Mycosis","enrollment":103},{"nctId":"NCT04345653","phase":"PHASE2","title":"Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"2020-04-14","conditions":"Covid19","enrollment":48},{"nctId":"NCT01815736","phase":"PHASE3","title":"Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2013-03-27","conditions":"HIV, HIV Infections","enrollment":1443},{"nctId":"NCT04696393","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2021-01-06","conditions":"Healthy Volunteers","enrollment":26},{"nctId":"NCT04332991","phase":"PHASE3","title":"Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2020-04-02","conditions":"Coronavirus, Acute Respiratory Infection, SARS-CoV Infection","enrollment":479},{"nctId":"NCT04389359","phase":"PHASE2, PHASE3","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion","status":"WITHDRAWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2020-09","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04472832","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2020-06-17","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT04301336","phase":"PHASE2, PHASE3","title":"Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2019-11-01","conditions":"Vaso-occlusive Crisis, Sickle Cell Disease, Sickle Cell Anemia in Children","enrollment":350},{"nctId":"NCT04403100","phase":"PHASE3","title":"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: \"The Hope Coalition - 1\"","status":"UNKNOWN","sponsor":"Cardresearch","startDate":"2020-06-03","conditions":"COVID-19, Coronavirus Infection, Virus Disease","enrollment":1968},{"nctId":"NCT04661709","phase":"PHASE4","title":"Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2021-03-01","conditions":"Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine","enrollment":502},{"nctId":"NCT04329923","phase":"PHASE2","title":"The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)","status":"TERMINATED","sponsor":"Ravi Amaravadi, MD","startDate":"2020-04-09","conditions":"COVID-19","enrollment":173},{"nctId":"NCT04565678","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2020-09-21","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT04342156","phase":"PHASE3","title":"Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19","status":"WITHDRAWN","sponsor":"Tan Tock Seng Hospital","startDate":"2020-04","conditions":"Coronavirus Infection, Hydroxychloroquine Adverse Reaction","enrollment":""},{"nctId":"NCT00236977","phase":"PHASE3","title":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-08","conditions":"Anemia","enrollment":182},{"nctId":"NCT04384458","phase":"NA","title":"Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis","status":"UNKNOWN","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2020-07-20","conditions":"Coronavirus Infections","enrollment":400},{"nctId":"NCT02086968","phase":"PHASE4","title":"Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2014-01-01","conditions":"Iron Deficiency Anemia Secondary to IBD or Gastric Bypass","enrollment":198},{"nctId":"NCT03149848","phase":"PHASE1","title":"Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2017-06-06","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":15},{"nctId":"NCT04392128","phase":"PHASE2","title":"Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)","status":"WITHDRAWN","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2020-09-02","conditions":"COVID19, Hematologic Malignancy","enrollment":""},{"nctId":"NCT04354441","phase":"PHASE2","title":"Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women","status":"WITHDRAWN","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2020-05","conditions":"COVID-19, SARS-CoV-2, Pregnant Women","enrollment":""},{"nctId":"NCT04434365","phase":"PHASE1, PHASE2","title":"Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-06-21","conditions":"Stable Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":24},{"nctId":"NCT04307693","phase":"PHASE2","title":"Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)","status":"TERMINATED","sponsor":"Asan Medical Center","startDate":"2020-03-11","conditions":"COVID-19","enrollment":65},{"nctId":"NCT04359537","phase":"PHASE2","title":"Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2020-05-01","conditions":"COVID 19","enrollment":200},{"nctId":"NCT03793556","phase":"NA","title":"Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor","status":"COMPLETED","sponsor":"SOFAR S.p.A.","startDate":"2017-05-05","conditions":"Gastro-oesophageal Reflux Disease","enrollment":72},{"nctId":"NCT02652624","phase":"PHASE3","title":"Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2016-02-19","conditions":"HIV-1 Infection","enrollment":472},{"nctId":"NCT03210480","phase":"PHASE4","title":"SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)","status":"TERMINATED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2017-03-28","conditions":"Bipolar Disorder","enrollment":85},{"nctId":"NCT03159845","phase":"PHASE2","title":"Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies","status":"COMPLETED","sponsor":"Azienda Ospedaliero, Universitaria Pisana","startDate":"2014-01-01","conditions":"Stem Cell Transplant Complications","enrollment":20},{"nctId":"NCT03443843","phase":"PHASE4","title":"A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-02-21","conditions":"Rhinitis, Allergic","enrollment":82},{"nctId":"NCT01803074","phase":"PHASE2","title":"Study to Evaluate a HIV Drug for the Treatment of HIV Infection","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2013-04-04","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":107},{"nctId":"NCT03991312","phase":"PHASE1","title":"Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2019-06-20","conditions":"Healthy Volunteers","enrollment":28},{"nctId":"NCT03429400","phase":"PHASE3","title":"Study of Oral Morphine Sulfate Administration in Pediatric Subjects","status":"COMPLETED","sponsor":"West-Ward Pharmaceutical","startDate":"2018-04-17","conditions":"Pain, Postoperative","enrollment":51},{"nctId":"NCT01705574","phase":"PHASE3","title":"Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2012-10-24","conditions":"Acquired Immunodeficiency Syndrome, HIV Infections","enrollment":583},{"nctId":"NCT01135563","phase":"PHASE1","title":"Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2010-04","conditions":"Solid Tumors, Central Nervous System Tumors","enrollment":14}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Oral Sulfate Tablet 2-Day","genericName":"Oral Sulfate Tablet 2-Day","companyName":"Pharmbio Korea Co., Ltd.","companyId":"pharmbio-korea-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oral sulfate acts as an osmotic laxative that draws water into the intestinal lumen to promote bowel evacuation. Used for Constipation, Bowel preparation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}